{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:18:42Z","timestamp":1792657122661,"version":"4.5.0"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>To study the effect of fexofenadine on extensive alopecia areata (AA), we evaluated retrospectively 121 patients with AA having alopecia in more than 50% of the scalp and followed them for at least 6\u00a0months. Patients were treated by immunotherapy using diphenylcyclopropenone or squaric acid dibutylester with or without oral fexofenadine. The regrowth score was estimated as decrease of Severity of Alopecia Tool (SALT) score. In AA with atopic background (atopic AA), the mean regrowth score of the fexofenadine group was 1.333 (<jats:italic>n<\/jats:italic>\u00a0=\u00a033) and that of the control 0.471 (<jats:italic>n<\/jats:italic>\u00a0=\u00a034). The fexofenadine group showed significantly better regrowth than control by Mann\u2013Whitney's <jats:italic>U<\/jats:italic>\u2010test (<jats:italic>P\u00a0=<\/jats:italic>\u00a00.00213). In non\u2010atopic AA, the mean regrowth score of the fexofenadine group was 1.303 (<jats:italic>n<\/jats:italic>\u00a0=\u00a033) and that of the control 1.048 (<jats:italic>n<\/jats:italic>\u00a0=\u00a021). There was no significant difference by Mann\u2013Whitney's <jats:italic>U<\/jats:italic>\u2010test (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.872). Together, fexofenadine is a helpful reagent in the treatment extensive atopic AA with contact immunotherapy.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2009.00647.x","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T00:30:43Z","timestamp":1240965043000},"page":"323-327","source":"Crossref","is-referenced-by-count":46,"title":["Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases"],"prefix":"10.1111","volume":"36","author":[{"given":"Shigeki","family":"INUI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"NAKAJIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"TODA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"ITAMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.4065\/70.7.628"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI551"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63151-3"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.03951.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.07.054"},{"key":"e_1_2_6_7_2","first-page":"60","article-title":"The effect of an anti\u2010allergic drug on the disease activity of alopecia areata","volume":"36","author":"Ogawa H","year":"1994","journal-title":"Skin Res"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.57.1206"},{"key":"e_1_2_6_9_2","first-page":"1473","article-title":"Efficacy of ebastine in the treatment of alopecia areata","volume":"115","author":"Yoshizawa Y","year":"2005","journal-title":"Jpn J Dermatol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2007.00401.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2006.00017.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70195-7"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.09.032"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70399-5"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01676.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000254503"},{"key":"e_1_2_6_17_2","first-page":"9","article-title":"Atopy and alopecia areata\u2010atopic alopecia areata","volume":"23","author":"Katsuoka K.","year":"1999","journal-title":"MB Derma"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000245677"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2001.100102.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.113237"},{"key":"e_1_2_6_21_2","first-page":"20","article-title":"Inhibition of cytokine\u2010induced expression of T\u2010cell cytokines by antihistamines","volume":"17","author":"Ashenager MS","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62712-3"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.061206"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700704"},{"key":"e_1_2_6_25_2","first-page":"2123","article-title":"Inhibitory effect by of fexofenadine hydrocloride on substance P\u2010induced inflammation in the skin","volume":"27","author":"Bae S","year":"2007","journal-title":"Prog Med"},{"key":"e_1_2_6_26_2","first-page":"58","article-title":"Inhibition by of fexofenadine hydrocloride on substance P production from dorsal root ganglion cells","volume":"5","author":"Asano K.","year":"2007","journal-title":"Skin Allergy Frontier"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2009.00647.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2009.00647.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:48:42Z","timestamp":1697176122000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2009.00647.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,28]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1346-8138.2009.00647.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2009.00647.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,28]]}}}